S-EPMC12927388 - First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours - OmicsDI

Unknown

Dataset Information

First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours

ABSTRACT:

SUBMITTER: Gomez-Roca C

PROVIDER: S-EPMC12927388 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature